REGENEREX PHARMA INC. (RGPX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RGPX Annual Balance Sheets →
Tracking balance sheet results across REGENEREX PHARMA INC. to Sep 30 2024 helps illustrate how Sep 30 2025's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2025)
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Assets
Cash & cash equivalent0.01
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments0.00
Total loans net0.04
Total Current Assets0.05
Equipment/Property/Plant Net0.05
Intangible Assets0.00
Other Assets, Noncurrent0.52
Total Assets0.62
Liabilities
Accounts Payable0.22
Accrued Liabilities, Current0.81
Short-term Debt2.85
Total Current Liabilities4.92
Total Long-term Debt0.00
Other liabilities, Noncurrent1.44
Total Liabilities5.32
Stockholders' Equity
Common Stock Value0.28
Additional Paid In Capital Common Stock4.64
Retained Earnings / Accumulated Deficit-9.62
Defined Benefit Plan and Other10.63
Common Stockholder's Equity-4.70
Total Stockholder's Equity-4.70
Liabilities & Stockholder's Equity0.62
4 historic quarters locked

Sign in to unlock the full REGENEREX PHARMA INC. balance sheet history.

About Regenerex Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250930)
  • Filed with the SEC: November 17, 2025
  • Source: ixform10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001472375-25-000140

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.